LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced the successful completion of ...

The analytical validation was conducted using an automated ELISA analyzer, which significantly enhances both performance and throughput compared to Immunovia's prior IMMray platform as well as ...

LUND, Sweden, March 19, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second ...

LUND, Sweden, March 24, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its ...

UNDATED (WKRC) - Researchers claim they have developed a process that can detect and identify nearly any infectious agent in a patient with just a single test. A new study from Nature Medicine ...

OWOSSO, Mich. — SAKOR Technologies Inc., a provider of high-performance dynamometer systems, released its DynoLAB™ GenV next-generation test automation controller, which allows even a non-programmer ...

The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. The FDA’s approval was based on findings ...

Keysight Technologies, Inc. (NYSE: KEYS) announced the successful completion of an interoperability test for its UXM-based Next Generation eCall (NG eCall) solution with HEAD acoustics GmbH, a global ...